Research showed that SERPINH1 could be a serum marker in diagnosis and prognosis assessment of GC (Liu et al., 2021) and potentially be the noninvasive biomarker reflecting the adenoma and carcinoma, especially CRC (Zhang et al., 2021). The gene discussed is SERPINH1; the disease is carcinoma.